What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

5 Pharmacy Data Analytics Blind Spots in Your Supply Chain Today

As a health system or hospital pharmacy leader, you know there are gaps in your supply chain operations. Take a moment to consider the end-to-end item level drug tracking required to comply with the CMS 340B Drug Pricing Program or Drug Supply Chain Security Act (DSCSA) requirements and the breaks in the chain are evident.  

Pharmacy data analytics blind spots aren’t just a problem when it comes to the nuances of regulatory compliance; rather, they cloud the decisions and actions made every day by your team members and anyone else who touches your processes and inventory. This includes: Read More >

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from 5 Pharmacy Data Analytics Blind Spots in Your Supply Chain Today

Name
Address
Subscribe